| The role of TGFβ in hematopoiesis and myeloid disorders A Bataller, G Montalban-Bravo, KA Soltysiak, G Garcia-Manero Leukemia 33 (5), 1076-1089, 2019 | 49 | 2019 |
| 41BB-based and CD28-based CD123-redirected T-cells ablate human normal hematopoiesis in vivo ML Baroni, DS Martinez, FG Aguera, HR Ho, M Castella, SR Zanetti, ... Journal for immunotherapy of cancer 8 (1), 2020 | 42 | 2020 |
| Acute myeloid leukemia with NPM1 mutation and favorable European LeukemiaNet category: outcome after preemptive intervention based on measurable residual … A Bataller, G Oñate, M Diaz‐Beyá, F Guijarro, A Garrido, S Vives, ... British Journal of Haematology 191 (1), 52-61, 2020 | 35 | 2020 |
| European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol A Bataller, A Garrido, F Guijarro, G Oñate, M Diaz-Beyá, M Arnan, ... Blood advances 6 (4), 1193-1206, 2022 | 27 | 2022 |
| A novel and efficient tandem CD19-and CD22-directed CAR for B cell ALL SR Zanetti, T Velasco-Hernandez, F Gutierrez-Agüera, VM Díaz, ... Molecular Therapy 30 (2), 550-563, 2022 | 27 | 2022 |
| Innovative strategies minimize engraftment syndrome in multiple myeloma patients with novel induction therapy following autologous hematopoietic stem cell transplantation G Gutiérrez-García, M Rovira, L Magnano, L Rosiñol, A Bataller, ... Bone Marrow Transplantation 53 (12), 1541-1547, 2018 | 24 | 2018 |
| CD34+CD19−CD22+ B-cell progenitors may underlie phenotypic escape in patients treated with CD19-directed therapies C Bueno, S Barrera, A Bataller, V Ortiz-Maldonado, N Elliot, S O’Byrne, ... Blood, The Journal of the American Society of Hematology 140 (1), 38-44, 2022 | 21 | 2022 |
| First report of CART treatment in AL amyloidosis and relapsed/refractory multiple myeloma A Oliver-Caldes, R Jiménez, M Español-Rego, MT Cibeira, ... Journal for Immunotherapy of Cancer 9 (12), 2021 | 21 | 2021 |
| Prognostic impact of DNMT3A mutation in acute myeloid leukemia with mutated NPM1 G Oñate, A Bataller, A Garrido, M Hoyos, M Arnan, S Vives, R Coll, ... Blood Advances 6 (3), 882-890, 2022 | 17 | 2022 |
| Near-haploidy and low-hypodiploidy in B-cell acute lymphoblastic leukemia: when less is too much O Molina, A Bataller, N Thampi, J Ribera, I Granada, P Velasco, JL Fuster, ... Cancers 14 (1), 32, 2021 | 17 | 2021 |
| Acute myeloid leukemia with inv (3)(q21. 3q26. 2)/t (3; 3)(q21. 3; q26. 2): Study of 61 patients treated with intensive protocols M Sitges, B Boluda, A Garrido, M Morgades, I Granada, E Barragan, ... European Journal of Haematology 105 (2), 138-147, 2020 | 16 | 2020 |
| Clinicobiological Characteristics and Outcomes of Patients with T-Cell Large Granular Lymphocytic Leukemia and Chronic Lymphoproliferative Disorder of Natural Killer Cells from … A Rivero, P Mozas, L Jiménez, M López-Guerra, D Colomer, A Bataller, ... Cancers 13 (15), 3900, 2021 | 14 | 2021 |
| Characteristics and clinical outcomes of patients with myeloid malignancies and DDX41 variants A Bataller, S Loghavi, Y Gerstein, A Bazinet, K Sasaki, KS Chien, ... American journal of hematology 98 (11), 1780-1790, 2023 | 10 | 2023 |
| Engraftment characterization of risk-stratified AML in NSGS mice R Díaz de la Guardia, T Velasco-Hernandez, F Gutiérrez-Agüera, ... Blood advances 5 (23), 4842-4854, 2021 | 10 | 2021 |
| A low lymphocyte-to-monocyte ratio is an independent predictor of poorer survival and higher risk of histological transformation in follicular lymphoma P Mozas, A Rivero, A Rivas-Delgado, F Nadeu, G Clot, JG Correa, ... Leukemia & Lymphoma 62 (1), 104-111, 2021 | 9 | 2021 |
| Improving security of autologous hematopoietic stem cell transplant in patients with light-chain amyloidosis G Gutierrez-Garcia, MT Cibeira, M Rovira, C Fernandez de Larrea, ... Bone marrow transplantation 54 (8), 1295-1303, 2019 | 8 | 2019 |
| Real-World Data on Chronic Myelomonocytic Leukemia: Clinical and Molecular Characteristics, Treatment, Emerging Drugs, and Patient Outcomes S Castaño-Díez, M López-Guerra, C Bosch-Castañeda, A Bataller, ... Cancers 14 (17), 4107, 2022 | 7 | 2022 |
| Prognostic risk signature in patients with acute myeloid leukemia treated with hypomethylating agents and venetoclax A Bataller, A Bazinet, CD DiNardo, A Maiti, G Borthakur, NG Daver, ... Blood Advances 8 (4), 927-935, 2024 | 6 | 2024 |
| Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort G Oñate, M Pratcorona, A Garrido, A Artigas-Baleri, A Bataller, M Tormo, ... Blood cancer journal 13 (1), 69, 2023 | 6 | 2023 |
| Clonal heterogeneity and rates of specific chromosome gains are risk predictors in childhood high‐hyperdiploid B‐cell acute lymphoblastic leukemia M Ramos‐Muntada, JL Trincado, J Blanco, C Bueno, ... Molecular oncology 16 (16), 2899-2919, 2022 | 6 | 2022 |
Jordi EsteveHospital Clínic, BarcelonaVerified email at clinic.cat
